CLINICAL AND PHARMACOKINETIC STUDY OF MITOXANTRONE (MXT) IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)

被引：0
|
作者：
LARSON, RA
DALY, KM
CHOI, KE
SINKULE, JA
HAN, DS
机构：
[1] UNIV CHICAGO,CHICAGO,IL 60637
[2] MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [31] PRELIMINARY-RESULTS IN SECONDARY ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) TREATED WITH IDARUBICIN
    PARMENTIER, C
    FINAUD, M
    SCHLUMBERGER, M
    MORARDET, N
    BERGER, R
    BAYLE, C
    CARDE, P
    HURTELOUP, P
    HAYAT, M
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1985, 27 (06): : 393 - 395
  • [32] SURFACE MARKER PHENOTYPE (SMP) AND BLAST MORPHOLOGY IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    STRAUSS, LC
    VAUGHAN, WP
    SCHWARTZ, JF
    BURKE, PJ
    KARP, JE
    CIVIN, CI
    CLINICAL RESEARCH, 1983, 31 (02): : A413 - A413
  • [33] SEQUENTIAL COMBINATION OF METHOTREXATE (MTX) AND ASPARAGINASE (ASP) IN ADVANCED ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    AMADORI, S
    TRIBALTO, M
    PASTORE, S
    CONCETTAPETTI, M
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 131 - 131
  • [34] ACQUIRED SELECTIVE FACTOR-X (FX) DEFICIENCY IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    BAUDO, F
    REDAELLI, R
    CAIMI, MT
    CATTANEO, D
    PEZZETTI, L
    NOSARI, AM
    DECATALDO, F
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 364 - 364
  • [35] CYTOGENETIC ANALYSES IN 301 CHILDREN WITH ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) - CORRELATION WITH PATIENT OUTCOME
    WOODS, WG
    BUCKLEY, J
    NESBIT, ME
    LAMPKIN, BC
    BERNSTEIN, I
    KIM, TH
    PIOMELLI, S
    KERSEY, JH
    FEIG, S
    HAMMON, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 823 - 823
  • [36] High single dose of mitoxantrone and cytarabine in acute non-lymphocytic leukemia: A pharmacokinetic and clinical study
    Mollgard, L
    Tidefelt, U
    Sundman-Engberg, B
    Lofgren, C
    Lehman, S
    Paul, C
    THERAPEUTIC DRUG MONITORING, 1998, 20 (06) : 640 - 645
  • [37] CHROMOSOME PATTERNS IN 26 SOUTH-AFRICAN CHILDREN WITH ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    BERNSTEIN, R
    MACDOUGALL, LG
    PINTO, MR
    CANCER GENETICS AND CYTOGENETICS, 1984, 11 (02) : 199 - 214
  • [38] MYELOID DIFFERENTIATION ANTIGEN EXPRESSION IN ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) CORRELATES WITH DISEASE STATUS
    TODD, MB
    BUCKLEY, PJ
    MALECH, HL
    ROME, LS
    WOLACK, JP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 185 - 185
  • [39] IS THE PROGNOSIS OF A RELAPSED ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) PATIENT IMPAIRED BY REINDUCTION WITH A NEW DRUG
    WIERNIK, PH
    MARKUS, SD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 174 - 174
  • [40] Efficacy and safety of mitoxantrone and etoposide (ME) in refractory and relapsed acute nonlymphocytic leukemia
    Pourtsidis, AG
    Baka, M
    Stasinopoulou, A
    Varvoutsi, M
    Paidoussi, C
    Bouhoutsou, D
    Kosmidis, HV
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1998, 5 (01): : 7 - 11
12345